Preclinical: Targeting NSD2, a Promising Strategy Against Treatment-Induced Neuroendocrine Prostate Cancer
/0 Comments/in Preclinical Research/by MaxASCO GU 2025: Gut-Driven Breakthrough, New Study Links Prostate Cancer Slowing to Phytochemicals and Probiotics
/0 Comments/in Clinical Trial, Localized/by MaxASCO GU 2025: Darolutamide Triplet Therapy Outperforms Alternatives in Advanced Prostate Cancer
/0 Comments/in Retrospective studies/by MaxAI Strikes Again: FDA Cleared an AI That Outperformed Human Pathologists in Missed Cases
/0 Comments/in Artificial Intelligence/by MaxUpdate Phase 1: Mevrometostat Shows Promise in Prostate Cancer by Targeting EZH2
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxThe Microbiome: A Frontline Barrier and Emerging Ally in Cancer Treatment
/0 Comments/in Clinical Trial, Not PCa related/by MaxBR111: A New ADC Therapy That Could Work Also For Prostate Cancer
/0 Comments/in Clinical Trial, Not PCa related/by MaxHyperthermia: Where Are We With Solid Tumors?
/0 Comments/in Hyperthermia, Preclinical Research/by MaxNewsletter 6/2025
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi, fellow fighters! This week, the updates are primarily in clinical research, we could call it the Nectin-4 week! As usual, we also have a podcast if you prefer to listen to the newsletter, you can find it HERE. Since I’ll need to […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide artificial intelligence ATM bispecific antibody bone metastasis BRCA cancer immunotherapy cancer treatment chemotherapy clinical trial clinical trials crispr darolutamide diet drug discovery drug repurposing drug resistance enzalutamide gut microbiome hormone therapy HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic cancer metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC neuroendocrine prostate cancer oncology personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics